An interventional study of VR-Enhanced Psychoeducational Program for Chronic Pain in Chronic Pain and Central Sensitization, sponsored by Badalona Serveis Assistencials. Completed at 4 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-28.
Sponsored by Badalona Serveis Assistencials · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 174 studies in Chronic Pain with a site in Spain — 34 open to participants now, 40 under way, 1 of them phase 3. Chronic Pain · Spain.
Among the 174 studies in Chronic Pain with a site in Spain, this one is the 28th largest by enrollment of the 141 interventional ones that give a count, is one of 20 that started in 2023, is one of 126 with no phase, and was the 135th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →34 of the 174 studies in Chronic Pain with a site in Spain are open now. Recruiting first, the newest first:
Biobizkaia Health Research Institute · Sites in Spain
Ages 35–75
Bernardino Clavo, MD, PhD · Sites in Spain
Ages 18+
Fundación Universidad Católica de Valencia San Vicente Mártir · Sites in Spain
Ages 18–70
University of Salamanca · Sites in Spain
Ages 65+
Investigación en Hemofilia y Fisioterapia · Sites in Spain
Ages 18+ · Men only
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
174 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 9 · Phase 4 3
First in 2003; this study’s year is marked. 20 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 128 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 66 across the 141 interventional studies, 268 across the 33 observational. Of the 113 that completed or were terminated, 17 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 174 have an industry lead sponsor. The 10 most frequent:
Badalona Serveis Assistencials is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Badalona Serveis Assistencials has 2 studies filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
8 of the studies in Chronic Pain with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07693998University of ValenciaPain Neuroscience Education for Chronic Pain | 2026-12-31 |
| NCT07467408Consorci Sanitari de TerrassaTreatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU) | 2026-12-31 |
| NCT07498569Universidad Miguel Hernandez de ElcheEffects of Percutaneous Electrical Stimulation in Patients With Chronic Supraspinatus Tendinopathy | 2027-06-01 |
| NCT07420387Investigación en Hemofilia y FisioterapiaEffectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy | 2027-06-28 |
| NCT07313280University of MalagaCentral Sensitization Syndromes and Post-Traumatic Stress in Women: Psychological Profile and Intervention | 2027-07 |
Add all 8 to your calendar (.ics) → With an account.
Among the 174 studies in Chronic Pain with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This pilot study aims to evaluate the integration of virtual reality (VR) with a psychoeducational program for individuals experiencing chronic pain and central sensitization. Chronic pain significantly hampers daily life, and the condition of central sensitization intensifies this challenge by making the pain more acute. Our research is grounded in the hypothesis that VR, when used to complement conventional psychoeducational methods, can enhance engagement and understanding of pain management strategies, thus potentially improving patient outcomes.
Key objectives and related measured variables include:
Usability and Feasibility: Evaluated through the System Usability Scale (SUS) responses from both participants and healthcare professionals, assessing the ease of use and integration of VR into the psychoeducational program.
Participant Engagement and Program Adherence: Determined by participants\' satisfaction with the VR system, using Likert scale questionnaires, and tracked through session attendance and program completion rates.
Impact on Chronic Pain Management and Emotional Well-being: Assessed through changes in the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), and the Hospital Anxiety and Depression Scale (HADS) collected at baseline, post-intervention, and 4-8 weeks follow-up Self-management of Chronic Pain: Monitored through the Central Sensitization Inventory (CSI) and changes in patient functionality and mobility using the EuroQol-5D-5L scale, measured at baseline, post-intervention, and 4-8 weeks follow-up.
Healthcare Professionals\' Perceptions: Investigated using SUS scores and qualitative feedback on the applicability and benefits of VR in clinical practice for chronic pain management.
Participants will complete eight 90-minute sessions, engaging with VR to supplement the program\'s content. This approach aims to provide immersive experiences that deepen the understanding and management of chronic pain. Participant feedback on the VR experience, alongside observed changes in pain management and overall well-being, will be critically examined.
By targeting individuals suffering from chronic pain, this research aims to offer healthcare professionals an innovative tool for enhancing pain management strategies. Integrating VR into psychoeducational content, the study seeks to promote more engaging and effective learning experiences, potentially leading to improved outcomes in chronic pain management.
The REDOCVR study is an innovative initiative to evaluate the adjunctive use of Virtual Reality (VR) within a psychoeducational framework for managing chronic pain and central sensitization. This initiative aims to harness the immersive potential of VR to enhance traditional psychoeducational strategies, thereby providing a more engaging and impactful patient experience.
Study Design Overview:
The study is structured as a prospective, non-randomized pilot intervention spanning September 2023 to December 2025 across select Primary Care Centers within Badalona Serveis Assistencials. Targeting adults with chronic pain, the intervention seeks to determine the feasibility, usability, and preliminary efficacy of incorporating VR into pain management protocols.
Recruitment and Selection Process Initial Information: The Primary Care Team is informed about the study and introduces it to potential participants that they identifiy in their daily clinical work, who are then scheduled for an evaluation through the centers electronic system.
Selection Procedure: Interested candidates are contacted via phone for further selection through a face-to-face recruitment visit, assessing eligibility by the Inclusion and Exclusion Criteria and collecting informed consent along with baseline data.
Data Collection and Analysis Specifics:
Data will be meticulously collected on paper before being digitized for analysis, ensuring a robust process for capturing and analyzing participant responses, feedback, and outcomes. This process underscores the study's commitment to methodological rigor and data integrity.
Ethical Considerations: Detailed information on informed consent, data management, privacy, and confidentiality will be addressed in the ethical considerations section.
Innovative Intervention Approach:
Participants are introduced to VR as a tool for understanding and managing their condition, with sessions designed to align VR experiences with educational content. The program includes 8 weekly sessions, each lasting 90 minutes, with VR experiences embedded into the curriculum to reinforce learning objectives and engage participants in their care process actively.
Technological and Methodological Framework:
The intervention leverages Oculus Quest 2 headsets, chosen for their standalone capability and immersive quality. Custom content developed using Unity software focuses on mindfulness, pain education, and self-management techniques, ensuring that VR sessions are directly relevant to participants' learning and therapeutic goals.
Overview of Sessions The intervention framework consists of 8 weekly, 90-minute sessions conducted in session rooms within healthcare centers. Each session incorporates a dedicated 15-20 minute segment for VR experiences designed to complement the session\'s theme and objectives.
Recruitment Visit A 30-minute recruitment visit initiates the study process, involving eligibility assessment through anamnesis, detailing the study\'s scope, and gathering informed consent from participants.
Session Breakdown
4 \& 6: Reeducation of the Central Nervous System (CNS) Through Physical Activity Engages patients in CNS reeducation activities using interactive VR games designed to encourage physical activity in a fun and engaging manner, overseen by a physiotherapist.
5: Psychological Aspects of Pain - Emotions and Thoughts Addresses emotions and thoughts associated with chronic pain through an educational VR session on emotional management techniques.
7: Emotions and Self-esteem Focuses on acceptance, self-esteem, and emotion management, incorporating a VR educational session on compassionate acceptance techniques.
8: Farewell A closing session that reviews covered content and concludes with a final VR session on attentive breathing techniques for relaxation and skill consolidation.
Expected Outcomes and Contributions:
Through a detailed exploration of VR's role in psychoeducation for chronic pain, the REDOCVR study aims to provide valuable insights into how digital health innovations can enhance traditional therapeutic modalities. The findings are anticipated to inform future interventions, guide clinical practice, and contribute to the broader dialogue on integrating technology into patient care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Withdrawal Criteria:
- Presence of VR-related side effects or patient's decision to withdraw.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm will undergo a comprehensive psychoeducational program tailored for chronic pain and central sensitization management, significantly enhanced with Virtual Reality (VR) experiences.
Behavioral: VR-Enhanced Psychoeducational Program for Chronic Pain
Participants undergo eight weekly sessions that include VR to learn pain physiology, mindfulness, and self-management techniques. Each session is 90 minutes, with 15-20 minutes of VR activities designed to complement the educational content. Activities simulate pain management exercises and mindfulness meditation. The program, led by pain management and VR specialists, aims to improve pain management skills, emotional well-being, and quality of life.
Participant Satisfaction with the VR-enhanced Psychoeducational Program as measured by the Participants Satisfaction Questionnaire
The Participant Satisfaction Questionnaire assesses with 10 itens various aspects of the VR-enhanced psychoeducational program, including content relevance, VR experience, and perceived benefits in managing chronic pain. This questionnaire uses a Likert scale for responses, providing a quantitative measure of participant satisfaction. The questionnaire's design allows for a comprehensive evaluation of the program's impact on participants, with higher scores indicating greater satisfaction.
Time frame: Immediately after the last intervention session (within 30 minutes of completing the 8th session)
Participants´ System Usability and VR Headset Comfort as assessed by the SUS for participants
The SUS is a two-part Likert Scale with options ranging from "Strongly disagree" to "I quite agree," designed to evaluate both the system's usability and the comfort of the VR headset used. Participants will respond to 16 statements, with 8 focused on system usability and 8 on headset comfort. Statements are rated on a scale from 1 to 5. For usability, positive experiences are reflected by statements 1, 3, 4, 6, and 7, while for headset comfort, statements assess aspects like weight, ease of use, and physical discomfort. The overall SUS score is calculated to assess usability and comfort, with higher scores indicating better usability and comfort levels.
Time frame: Immediately after the last intervention session (within 30 minutes of completing the 8th session)
Professionals System Usability as measured by the SUS for Professionals
The SUS for Professionals is designed to evaluate healthcare professionals' perceptions of the VR system's usability within the clinical setting for this educational program. This assessment uses a Likert Scale from "Strongly disagree" to "I quite agree," focusing on ease of use, integration into practice, and the system's effectiveness in enhancing patient care. Higher scores on the SUS for Professionals indicate a positive assessment of the system's usability and potential impact on patient treatment.
Time frame: Immediately after the last intervention session (within 30 minutes of completing the 8th session)
Mental Well-being as assessed by the WEMWBS-7
The 7-item Warwick-Edinburgh Mental Well-being Scale (WEMWBS-7) is a concise version designed to efficiently assess mental well-being, focusing predominantly on functioning aspects. It is characterized by better scaling properties, enhancing the precision of measuring differences in scores. It has been demonstrated to be responsive to change in clinical populations undergoing psychotherapy at both group and individual levels. The minimal detectable change at the individual level is calculated as 1 or 3 points, with total scores requiring transformation according to a provided table. This scale is chosen for its brevity and focus on functioning, making it particularly suited for evaluations where time is constrained but a precise and responsive measure of mental well-being is needed.
Time frame: Baseline and immediately after the last intervention session (within 30 minutes of completing the 8th session)
Anxiety and Depression Severity as measured by the HADS
The Hospital Anxiety and Depression Scale (HADS) is a self-administered instrument consisting of 14 items divided into two subscales: one for anxiety and one for depression, with interspersed items. It focuses on anhedonia as a core aspect of the depression subscale, a primary symptom distinguishing depression from anxiety. Items are scored on a 4-point Likert frequency scale (0-3), with total scores ranging from 0 to 21 for each subscale. Higher scores indicate greater symptom severity. Scores above eleven suggest a definitive "case" of anxiety or depression, while scores above eight are considered "probable cases." The scale's internal consistency for the Spanish population in a fibromyalgia study was α=.83 for anxiety and α=.87 for depression.
Time frame: Baseline and immediately after the last intervention session (within 30 minutes of completing the 8th session)
Central Sensitization as measured by the CSI
The Central Sensitization Inventory (CSI) is utilized to assess the extent of central sensitization symptoms in participants. It comprises questions rated on a 5-point scale, from 0 ("never") to 4 ("always"), with the total score achievable being 100. This summed response quantifies the level of self-reported symptomology related to central sensitization. Higher CSI scores indicate greater symptom severity, with a score exceeding 40 suggesting the presence of central sensitization. This measure is critical for identifying participants experiencing heightened sensitivity to pain, a key factor in chronic pain syndromes, and assessing the effectiveness of interventions aimed at managing these symptoms.
Time frame: Baseline and immediately after the last intervention session (within 30 minutes of completing the 8th session)
Changes in Functionality and Mobility as assessed by the EuroQol-5D-5L Scale
The EuroQol-5D-5L scale measures changes in participants' functionality and mobility. This assessment covers five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with a scoring system that highlights the degree of difficulty in each area. Improvements are indicated by lower scores in dimensions related to pain/discomfort and better scores in mobility and self-care.
Time frame: Baseline and immediately after the last intervention session (within 30 minutes of completing the 8th session)
Adherence to the VR-enhanced Psychoeducational Program as indicated by session attendance and program completion rates
Program adherence is measured by tracking participants' attendance at the sessions and their completion of the entire VR-enhanced psychoeducational program. High attendance and completion rates are indicators of the program's acceptability and participants' engagement with the VR intervention.
Time frame: After the last intervention session, up to 16 weeks
Participant Feedback as recorded on the Participant Comment Sheet
The Participant Comment Sheet is designed to capture immediate, qualitative feedback from participants at the end of each VR-enhanced psychoeducational session. This open-ended feedback mechanism allows participants to express their thoughts, experiences, and suggestions regarding the session they just completed. The comments provide valuable insights into the program's reception, areas for improvement, and the overall impact from the participant's perspective. Collecting this data after each session enables ongoing evaluation and potential adjustment of the program based on participant feedback, enhancing the relevance and effectiveness of the intervention.
Time frame: Immediately at the end of each session
Plan to share: Yes — In our study, outcome data initially collected on paper are manually entered into Excel sheets, creating a digitized dataset that reflects the raw results of the research. This digitization process is conducted with precision to ensure accuracy and reliability of the data. The digitalized data are then coded and stored securely within the BSA intranet, in a protected digital folder accessible only to authorized personnel. Given the manual transcription and internal storage of these data, our plan to share Individual Participant Data (IPD) includes specific steps tailored to maintain data integrity, confidentiality, and compliance with ethical standards:
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: The digitized IPD will be made available to approved researchers starting 12 months after the publication of the main study results. This window allows sufficient time for the meticulous preparation of the data for external use. The data will be accessible for a period of up to 3 years, during which requests for access can be submitted and reviewed.
Access criteria: Access to IPD will be granted to researchers submitting scientifically valid proposals that align with ethical guidelines. A review committee will evaluate proposals based on their objectives, methodology, and compliance with data protection standards. Successful applicants will sign a data use agreement detailing secure data handling and confidentiality requirements. Instructions for secure data access, including anonymization protocols and secure transfer methods, will be provided to approved researchers. Data will be accessible via a secure platform within the BSA intranet, ensuring data integrity and participant privacy are maintained.
Ran from Dec 2023 to primary completion in Dec 2025, 24 months.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 24 months is above that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Badalona Serveis Assistencials